29472

29472
European Medicines Agency (EMA). SGLT2 inhibitors: information on potential risk of toe amputation to be included in prescribing information: Diabetes patients reminded of importance of preventative foot care. 2017 (EMA/118223/2017) [cited: 2019-07-02]. https://www.ema.europa.eu/en/medicines/human/referrals/sglt2-inhibitors-previously-canagliflozin
Einstellungen
29472
nein
Kategorisierung
Sitemap
nein
Wird geladen
zuletzt verändert: 17.03.2021 | 21:33 Uhr